BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35906934)

  • 21. Application of Cut-Points for Low Muscle Strength and Lean Mass in Mobility-Limited Older Adults.
    Grosicki GJ; Travison TG; Zhu H; Magaziner J; Binder EF; Pahor M; Correa-de-Araujo R; Cawthon PM; Bhasin S; Orwig D; Greenspan S; Manini T; Massaro J; Santanasto A; Patel S; Fielding RA
    J Am Geriatr Soc; 2020 Jul; 68(7):1445-1453. PubMed ID: 32633836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Slow Walking Speed From a Pooled Cohort Analysis: Sarcopenia Definitions, Agreement, and Prevalence in Australia and New Zealand.
    Zanker J; Scott D; Szoeke C; Vogrin S; Patel S; Blackwell T; Bird S; Kirk B; Center J; Alajlouni DA; Gill T; Jones G; Pasco JA; Waters DL; Cawthon PM; Duque G
    J Gerontol A Biol Sci Med Sci; 2023 Dec; 78(12):2415-2425. PubMed ID: 37428864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARC-F Is Inaccurate to Identify Geriatric Rehabilitation Inpatients at Risk for Sarcopenia: RESORT.
    Dedeyne L; Reijnierse EM; Pacifico J; Kay JE; Maggs P; Verschueren S; Tournoy J; Gielen E; Lim WK; Maier AB
    Gerontology; 2022; 68(3):252-260. PubMed ID: 34062544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (Dis) Agreement between the first and the recent European consensus on definition and diagnosis for sarcopenia in kidney transplant patients.
    Limirio LS; Santos HO; Dos Reis AS; de Oliveira EP
    Eur J Clin Nutr; 2020 Jul; 74(7):1104-1108. PubMed ID: 31767990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent sarcopenia definitions-prevalence, agreement and mortality associations among men: Findings from population-based cohorts.
    Westbury LD; Beaudart C; Bruyère O; Cauley JA; Cawthon P; Cruz-Jentoft AJ; Curtis EM; Ensrud K; Fielding RA; Johansson H; Kanis JA; Karlsson MK; Lane NE; Lengelé L; Lorentzon M; McCloskey E; Mellström D; Newman AB; Ohlsson C; Orwoll E; Reginster JY; Ribom E; Rosengren BE; Schousboe JT; Shiroma EJ; Harvey NC; Dennison EM; Cooper C;
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):565-575. PubMed ID: 36604970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle Weakness and Walking Slowness for the Identification of Sarcopenia in the Older Adults from Northern Brazil: A Cross-Sectional Study.
    Lima AB; Henrinques-Neto D; Ribeiro GDS; Gouveia ER; Baptista F
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional study on sarcopenia using EWGSOP1 and EWGSOP2 criteria with regional thresholds and different adjustments in a specific geriatric outpatient clinic.
    Savas S; Taşkıran E; Sarac FZ; Akcicek F
    Eur Geriatr Med; 2020 Apr; 11(2):239-246. PubMed ID: 32297186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic differences and agreement between the original and revised European Working Group (EWGSOP) consensus definition for sarcopenia in community-dwelling older adults with type 2 diabetes mellitus.
    Villani A; McClure R; Barrett M; Scott D
    Arch Gerontol Geriatr; 2020; 89():104081. PubMed ID: 32485520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of standard
    Bahat G; Kilic C; Altinkaynak M; Akif Karan M
    Aging Male; 2020 Dec; 23(5):1564-1569. PubMed ID: 33432867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort - a comparison to the EWGSOP2 cut-off points.
    Huemer MT; Kluttig A; Fischer B; Ahrens W; Castell S; Ebert N; Gastell S; Jöckel KH; Kaaks R; Karch A; Keil T; Kemmling Y; Krist L; Leitzmann M; Lieb W; Meinke-Franze C; Michels KB; Mikolajczyk R; Moreno Velásquez I; Pischon T; Schipf S; Schmidt B; Schöttker B; Schulze MB; Stocker H; Teismann H; Wirkner K; Drey M; Peters A; Thorand B
    Age Ageing; 2023 Jan; 52(1):. PubMed ID: 36702514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Associated Factors of Sarcopenia in Singaporean Adults-The Yishun Study.
    Pang BWJ; Wee SL; Lau LK; Jabbar KA; Seah WT; Ng DHM; Ling Tan QL; Chen KK; Jagadish MU; Ng TP
    J Am Med Dir Assoc; 2021 Apr; 22(4):885.e1-885.e10. PubMed ID: 32693999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of sarcopenia in community-dwelling older adults using the definition of the European Working Group on Sarcopenia in Older People 2: findings from the Korean Frailty and Aging Cohort Study.
    Kim M; Won CW
    Age Ageing; 2019 Nov; 48(6):910-916. PubMed ID: 31329815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.
    Scott D; Blyth F; Naganathan V; Le Couteur DG; Handelsman DJ; Waite LM; Hirani V
    Clin Nutr; 2023 Sep; 42(9):1610-1618. PubMed ID: 37481869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus.
    de Freitas MM; de Oliveira VLP; Grassi T; Valduga K; Miller MEP; Schuchmann RA; Souza KLA; de Azevedo MJ; Viana LV; de Paula TP
    Exp Gerontol; 2020 Apr; 132():110835. PubMed ID: 31954325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic value of the Short Physical Performance Battery for sarcopenia.
    Phu S; Kirk B; Bani Hassan E; Vogrin S; Zanker J; Bernardo S; Duque G
    BMC Geriatr; 2020 Jul; 20(1):242. PubMed ID: 32660438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of muscle dysfunction concomitant with osteoporosis in a home-dwelling Danish population aged 65-93 years - The Copenhagen Sarcopenia Study.
    Nielsen BR; Andersen HE; Haddock B; Hovind P; Schwarz P; Suetta C
    Exp Gerontol; 2020 Sep; 138():110974. PubMed ID: 32464171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Owen PJ; Daly RM; Dalla Via J; Mundell NL; Livingston PM; Rantalainen T; Fraser SF
    Calcif Tissue Int; 2019 Oct; 105(4):403-411. PubMed ID: 31317232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle Strength Definitions Matter: Prevalence of Sarcopenia and Predictive Validity for Adverse Outcomes Using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) Criteria.
    Chew J; Yeo A; Yew S; Lim JP; Tay L; Ding YY; Lim WS
    J Nutr Health Aging; 2020; 24(6):614-618. PubMed ID: 32510114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The longitudinal associations of sarcopenia definitions with functional deterioration: a comparative study.
    Bahat G; Bozkurt ME; Ozkok S; Kilic C; Karan MA
    Aging Clin Exp Res; 2023 Oct; 35(10):2089-2099. PubMed ID: 37486546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Selected Muscle Strength and Body Mass Cut Points for the Diagnosis of Sarcopenia in Men and Women With or at Risk for HIV Infection.
    Erlandson KM; Travison TG; Zhu H; Magaziner J; Correa-de-Araujo R; Cawthon PM; Bhasin S; Manini T; Fielding RA; Palella FJ; Kingsley L; Lake JE; Sharma A; Tien PC; Weber KM; Yin MT; Brown TT
    J Gerontol A Biol Sci Med Sci; 2020 Jun; 75(7):1338-1345. PubMed ID: 32301484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.